Rapid cerebrovascular reactivity mapping: Enabling vascular reactivity information to be routinely acquired by Blockley, Nicholas P. et al.
NeuroImage 159 (2017) 214–223Contents lists available at ScienceDirect
NeuroImage
journal homepage: www.elsevier .com/locate/neuroimageRapid cerebrovascular reactivity mapping: Enabling vascular reactivity
information to be routinely acquired
Nicholas P. Blockley a,*, James W. Harkin b, Daniel P. Bulte c
a FMRIB Centre, Nufﬁeld Department of Clinical Neurosciences, University of Oxford, Oxford, UK
b Department of Physics, University of Oxford, Oxford, UK
c Institute of Biomedical Engineering, Engineering Science, University of Oxford, Oxford, UKA R T I C L E I N F O
Keywords:
Cerebrovascular reactivity
Magnetic Resonance Imaging
Hypercapnia challenge
BOLD* Corresponding author. FMRIB Centre, Nufﬁeld Depar
E-mail address: nicholas.blockley@ndcn.ox.ac.uk (N.P
http://dx.doi.org/10.1016/j.neuroimage.2017.07.048
Received 18 January 2017; Received in revised form 17 J
Available online 26 July 2017
1053-8119/© 2017 The Authors. Published by Elsevier InA B S T R A C T
Cerebrovascular reactivity mapping (CVR), using magnetic resonance imaging (MRI) and carbon dioxide as a
stimulus, provides useful information on how cerebral blood vessels react under stress. This information has
proven to be useful in the study of vascular disorders, dementia and healthy ageing. However, clinical adoption of
this form of CVR mapping has been hindered by relatively long scan durations of 7–12 min. By replacing the
conventional block presentation of carbon dioxide enriched air with a sinusoidally modulated stimulus, the aim of
this study was to investigate whether more clinically acceptable scan durations are possible. Firstly, the con-
ventional block protocol was compared with a sinusoidal protocol of the same duration of 7 min. Estimates of the
magnitude of the CVR signal (CVR magnitude) were found to be in good agreement between the stimulus pro-
tocols, but estimates of the relative timing of the CVR response (CVR phase) were not. Secondly, data from the
sinusoidal protocol was reanalysed using decreasing amounts of data in the range 1–6 min. The CVR magnitude
was found to tolerate this reduction in scan duration better than CVR phase. However, these analyses indicate that
scan durations in the range of 3–5 min produce robust data.1. Introduction
Whilst there are many clinical techniques to investigate cerebral
physiology at rest, methods to examine the brain during dynamic
changes in demand are few in number. Resting perfusion measurement
techniques using Computed Tomography (CT) or Magnetic Resonance
Imaging (MRI) are able to conﬁrm that the tissue is well supplied at rest,
but they do not provide information on how the vasculature will react
during increases in demand. By introducing a physiological challenge
this aspect of cerebrovascular health can be revealed. There are twomain
vasoactive challenges that can be used to provide a stress test of the ce-
rebral vasculature: acetazolamide and carbon dioxide. Acetazolamide
provides a large physiological challenge by maximally dilating cerebral
arterioles. However, its effects are relatively long lasting (~30 min) and
it therefore has the potential to interfere with the accuracy of other
diagnostic measurements made in the same session. In contrast, carbon
dioxidemay have a weaker vasodilatory effect, but it is rapidly cleared by
the lungs enabling multiple short repeated challenges to be performed
without interfering with subsequent measurements. When combined
with an imaging modality this carbon dioxide stimulus, often termed atment of Clinical Neurosciences, Univ
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c. This is an open access article undehypercapnia challenge, enables cerebrovascular reactivity (CVR) to be
mapped at the tissue level. The most common imaging modality for this
purpose is MRI. Measurements have been performed using both Arterial
Spin Labelling (ASL) (Mandell et al., 2008) and Blood Oxygenation Level
Dependent (BOLD) (Rostrup et al., 1994) weighted techniques, each with
their own advantages and disadvantages. BOLD weighted imaging offers
higher spatial and temporal resolution and a higher signal to noise ratio
(SNR) than ASL, whereas ASL provides quantitative measurements of
perfusion change and BOLD does not. In practice, BOLD weighted mea-
surements are more commonly used due to their higher sensitivity, more
widespread availability and ease of analysis.
The information provided by CVRmeasurements has proven useful in
a range of research applications, but has yet to cross over into clinical
practice. CVR mapping has perhaps made the biggest impact in the study
of vascular disorders of the brain. In patients with unilateral carotid
stenosis it has been used to show that CVR is reduced in both the affected
and unaffected hemisphere (Sam et al., 2014). In Moyamoya patients,
who share similar pathological narrowing of cerebral vessels, BOLD
based CVR has been shown to give comparable results with ASL based
CVR (Mandell et al., 2008). CVR measurements have also been acquiredersity of Oxford, John Radcliffe Hospital, Headington, Oxford, OX3 9DU, UK.
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Costa et al., 2013) or in rare conditions such as MELAS (Rodan et al.,
2015) where in both cases only limited biomarkers are available. CVR
has also shown promise as a biomarker in dementia and healthy ageing
research. In Alzheimer's disease CVR has been shown to be altered in
patients with different variants of the APOE gene (Suri et al., 2015). CVR
has also been used to investigate the effect of healthy ageing on brain
haemodynamics (Gauthier et al., 2013).
However, the clinical adoption of hypercapnia based CVR mapping
has so far been hindered by two main challenges: (i) relatively long scan
times and (ii) long patient preparation times. Clinical MRI examinations
are typically split into discrete diagnostic measurements of approxi-
mately 5 min in duration. However, currently CVR examinations are
between 7 and 12 min in duration, meaning that compromises in diag-
nostic protocols must be made to accommodate such measurements.
Preparation of patients adds an additional time penalty that is dependent
on the means of gas administration and/or gas sampling. However, in
this study we concentrate on the question of reducing the duration of the
CVR examination.
Typically, hypercapnic gas challenges are presented in blocks inter-
leaved with a baseline air breathing condition. One popular gas protocol
used by researchers in Toronto involves the use of two hypercapnic
blocks of differing duration; an initial short block followed by a second
much longer block (Spano et al., 2012). This protocol has also been used
to derive information about the relative timing of the CVR response using
Transfer Function Analysis (TFA) (Dufﬁn et al., 2015) or by ﬁtting a
temporal model of the vascular response (Poublanc et al., 2015). This
timing information has been suggested to be reﬂective of regional vari-
ations in blood transit time (Blockley et al., 2010) or variations in
vascular response time i.e. the rate at which the CVR response develops
(Dufﬁn et al., 2015). Overall scan time can be reduced by shortening the
duration of hypercapnia blocks. However, as the block duration is
reduced, vascular response delays may become an increasingly large
fraction of the block duration, particularly in disease (Poublanc et al.,
2013). Since this delay is not typically accounted for in the analysis of
such data, this may cause CVR measurements to be underestimated.
Alternatively, in the limit of short blocks a sinusoidally varying stimulus
has several advantages that enable the effect of local vascular response
delays to be overcome due to the mathematical properties of a sinusoid
(Blockley et al., 2010). Transit and vascular response delays can be
modelled as a phase shift of the inputted sinusoidal stimulus providing
two major beneﬁts. Firstly, the resulting BOLD response can be modelled
as a sine wave with the same frequency as the stimulus and a local phase
shift to correct for transit and vascular response delay at the voxel level.
In this context the ﬁtted amplitude of the sinusoid reﬂects CVR and the
phase of the sinusoid provides similar timing information to TFA. Sec-
ondly, this means that a regressor based on end-tidal partial pressure of
carbon dioxide (PETCO2) is not required. This simpliﬁes the estimation of
CVR maps, since additional data does not need to be transferred to the
analysis workstation, and may even provide the option of CVR map
generation on the scanner. Furthermore, the sinusoidal stimulus protocol
can be retrospectively reanalysed with fewer stimulus cycles, or fractions
of cycles, to examine the effect of reducing scan time, since it is not the
duration of the stimulus that is important but the stimulus frequency.
Finally, because sinusoidal stimuli are smoothly varying they are less
demanding for automated gas administration systems to generate and are
likely to be more comfortable for participants as the peak carbon dioxide
level is only experienced for one or two breaths in each cycle.
Therefore, the aim of this study was to develop a rapid CVR technique
based on a sinusoidal hypercapnic stimulus. Comparison was made with
a commonly applied block paradigm, which we term the Toronto pro-
tocol (Spano et al., 2012). Both protocols produce estimates of vascular
reactivity and the timing of this reactivity, which to prevent ambiguity
we describe as CVR magnitude and CVR phase, respectively. Firstly, es-
timates of CVRmagnitude and CVR phase were compared for the Toronto
and Sinusoid protocols with the same scan duration. Secondly, the215amount of data included in the analysis of the Sinusoid protocol was
progressively reduced to investigate how rapidly CVR information can
be acquired.
2. Methods
2.1. Imaging
All imaging was performed on a Siemens Prisma 3T scanner (Siemens
Healthineers, Erlangen, Germany) using the body transmit coil and the
vendors 32-channel receive coil. This study was approved by the Central
University Research Ethics Committee (CUREC) at the University of
Oxford. Ten healthy volunteers (age range 19–21, 5 female) were
recruited and informed written consent obtained. Functional imaging
consisted of BOLD-weighted EPI images with the following pulse
sequence parameters: repetition time (TR) 2 s, echo time (TE) 30ms, ﬁeld
of view (FOV) 220 mm  220 mm, matrix 64  64, slices 24, slice
thickness 5 mm, slice gap 0.5 mm, ﬂip angle 80, GRAPPA 2. Each
functional scan had a duration of 7 min, resulting in the acquisition of
210 imaging volumes. A ﬁeld map was acquired using a 2D Fast Low
Angle Shot (FLASH) method with the following parameters: TR 378 ms,
TE1/TE2 4.92 ms/7.38 ms, FOV of 220 mm  220 mm, matrix 64  64,
slices 24, slice thickness 4.5 mm, slice gap 0.45 mm, ﬂip angle 45.
Finally, a high resolution T1-weighted structural image was acquired for
each subject using a 3D Magnetisation Prepared Rapid Acquisition
Gradient Echo (MPRAGE) pulse sequence (Mugler and Brookeman,
1990) with the following parameters: TR 1.9s, TE 3.74 ms, FOV
174 mm  192 mm  192 mm, matrix 116  128  128, ﬂip angle 8,
inversion time (TI) 904 ms.
Details on how to access the imaging data that underlies this study
can be found in Appendix A.
2.2. Respiratory stimulus
Hypercapnia challenges were delivered by a computer controlled gas
blender (RespirAct™ Gen 3, Thornhill Research Inc., Toronto, Canada)
that implements a prospective algorithm for the targeting of blood gases
(Slessarev et al., 2007). Subjects were ﬁtted with a sequential gas de-
livery (SGD) breathing circuit, which was sealed to the face using ad-
hesive tape (Tegaderm, 3M Healthcare, St. Paul, Minnesota, USA) to
prevent the entrainment of room air. Subjects were then asked to sit
comfortably outside the scanner whilst the prospective algorithm was
calibrated. The subject's speciﬁc resting end-tidal carbon dioxide and
oxygen partial pressures (PETCO2 and PETO2, respectively) were ﬁrst
determined by averaging the ﬁrst ten or so breaths into the breathing
mask. The calibration consisted of initiating a baseline targeted at the
subject's speciﬁc resting PETCO2 and PETO2. Initial estimates of the sub-
ject's VCO2 and VO2 (their resting production/consumption of CO2/O2)
based on height, weight and age were reﬁned until a constant baseline
was achieved with minimal drift. A brief presentation of the sinusoidal
hypercapnic stimulus was then administered to the subject to prepare
them for the sensations they might encounter whilst in the scanner.
Gas stimulus protocols (Fig. 1a) were tailored to each subject's resting
PETCO2 and PETO2 baselines. Modulations in PETCO2 were targeted rela-
tive to baseline, whilst PETO2 was targeted to remain constant at baseline
throughout. The Toronto gas protocol consisted of two blocks of hyper-
capnia, each with step changes of þ10 mmHg; one of 45 s duration and
the other 120 s. The former was preceded by a 60 s baseline and the latter
by a 90 s baseline, with a ﬁnal baseline period of 105 s completing the
7 min protocol (Sobczyk et al., 2015). The sinusoidal gas protocol was
composed of seven sinusoidal cycles, each with a period of 60 s. This was
the minimum period we could achieve using the automated gas admin-
istration equipment and hence the highest frequency. Experimental noise
is expected to be proportional to the reciprocal of frequency and hence a
higher frequency stimulus is preferred to minimise the noise contribu-
tion. To produce a purely hypercapnic stimulus, i.e. only increases in
Fig. 1. Data analysis pipeline for Toronto and Sinusoid protocols. It is important for the
end-tidal CO2 regressor to be well-aligned with the BOLD data in the Toronto protocol to
avoid underestimating changes in CVR Magnitude. The Sinusoid protocol analysis is
inherently insensitive to such vascular response delays and does not require this step.
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±5 mmHg at þ5 mmHg above resting baseline i.e. a variation in PETCO2
from resting baseline to þ10 mmHg (Fig. 1a). By spanning the same
PETCO2 range as the Toronto protocol, we aim to operate on the same
portion of the vascular response curve. In this implementation, the pro-
spective algorithm is very tolerant of increases in ventilation rate
compared with the baseline level during calibration, but not reductions
in ventilation. Therefore, subjects were coached to maintain their
ventilation rate over the scanner intercom should it be observed to have
dropped below baseline levels.
During the presentation of each 7 min stimulus protocol, imaging was
performed using the 7 min BOLD-weighted EPI pulse sequence described
above. Synchronisation of the respiratory and imaging protocols was
manually initiated.
2.3. Image analysis
The basic image analysis pipeline is summarised in Fig. 1b. Imaging
data from the two stimulus protocols were ﬁrst submitted to a common
pre-processing stage including motion correction (Jenkinson et al.,
2002), ﬁeldmap based EPI unwarping (Jenkinson et al., 2012), slice
timing correction, removal of non-brain tissue (Smith, 2002) and spatial
smoothing with a 5 mm FWHM kernel (Smith and Brady, 1997). High
pass temporal ﬁltering was also performed with cut-off values of 100 s
(10 mHz) and 200 s (5 mHz) for the Sinusoid and Toronto protocols,216respectively. Images from the Toronto protocol were registered to MNI
space via the subject's structural image (Greve and Fischl, 2009; Jen-
kinson et al., 2002). This registration was used to transform the MNI
structural atlas (Mazziotta et al., 2001) and segmented structural images
(Zhang et al., 2001) to functional space. Finally, the Sinusoid protocol
images were registered to the Toronto protocol images.
The FMRIB Expert Analysis Tool (FEAT) was used to perform model-
based multiple regression analysis (Woolrich et al., 2009). Motion pa-
rameters were not included in this analysis. For the Sinusoid protocol, the
model was deﬁned by sine and cosine terms with time periods of 60 s
(equivalent to 16.7 mHz). This model is based on the observation that a
cosine with arbitrary phase can be described by the sum of a sine and a
cosine with equal frequency (ω), but different amplitudes (A and B). The
amplitudes in Eq. (1) can be obtained from the GLM analysis.
A cosðωtÞ þ B sinðωtÞ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
A2 þ B2
p
cos

ωt  tan1ðB=AÞ (1)
For the Toronto protocol, the model was deﬁned by the measured
PETCO2 change during the challenge experienced by each subject. This
PETCO2 timecourse must ﬁrst be synchronised with the associated BOLD
signal changes in the brain, due to intersubject differences in blood
arrival time. This was achieved by extracting themean whole brain BOLD
signal change, using the mask generated during the brain extraction
process, and ﬁnding themaximum cross-correlation with the PETCO2 data
interpolated to the BOLD sampling frequency. High pass temporal
ﬁltering with the same cut-off as the imaging data was then applied and
the temporal derivative included as an additional regressor.
From this analysis several outputs can be produced. Statistical maps
were generated and thresholded at the voxel level with a corrected voxel
P threshold of 0.05. The effect of the sine and cosine terms in the sinu-
soidal analysis were combined by using an F-test, whereas for the Tor-
onto analysis a single T-test was used. Maps of CVR magnitude were
calculated from the parameter estimates (PE) of the GLM analysis using
Eq. (2) for the Sinusoid protocol and Eq. (3) for the Toronto protocol,
where Smean is the mean BOLD signal baseline and ΔPETCO2 is the change
in end-tidal partial pressure of CO2. Normalisation by ΔPETCO2 is
included to control for difference in the stimulus magnitude
across subjects.
CVRmagsin ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
PE2sin þ PE2cos
q
Smean ΔPETCO2
(2)
CVRmagtor ¼
PEPETCO2
Smean ΔPETCO2
(3)
Despite the use of a GLM analysis in this work, in contrast to the
Fourier analysis used previously (Blockley et al., 2010), it is still possible
to calculate maps of CVR phase from the sinusoidal protocol by using
Eq. (4).
CVRphasin ¼ tan1
PEsin
PEcos
(4)
To provide CVR phase estimates that are comparable with the Tor-
onto protocol, maps were produced using the whole brain phase as a
reference i.e. equivalent to the synchronisation performed for the Tor-
onto protocol. This was achieved by extracting a whole brain BOLD
signal timecourse and estimating the CVR phase using Eq. (4). This global
phase value was then subtracted from the CVR phase estimates from
each voxel.
For the Toronto protocol Transfer Function Analysis (TFA) (Dufﬁn
et al., 2015) was used to estimate CVR phase. Since this is a Fourier based
method, and as such no standard tools exist, it was implemented in
MATLAB (Mathworks, Natick, MA, USA). The normalised transfer func-
tion H(f) is calculated by dividing the cross power spectral density
(CPSD) of the BOLD and PETCO2 timecourses by the power spectral
density (PSD) of the BOLD timecourse. Both the BOLD and PETCO2
N.P. Blockley et al. NeuroImage 159 (2017) 214–223timecourses were demeaned prior to spectral analysis.
Hðf Þ ¼ CPSDBOLD;PETCO2 ðf Þ
PSDBOLDðf Þ (5)
CVR phase can be calculated from the real and imaginary parts of
H(f), denoted by subscript r and i, at the frequency of interest. Previously
this was selected as 10 mHz, which had been found to be the frequency
with the highest coherence (Dufﬁn et al., 2015). However, in order to
enable comparison with the Sinusoid protocol, 16.7 mHz was used in this
study. Coherence analysis of the whole brain BOLD signal with the
PETCO2 recording reveals that this results in only a small reduction in
coherence (Fig. S1).
CVRphator ¼ tan1
Hðf Þi
Hðf Þr
(6)
The use of a GLM analysis also enables the errors in measurements of
CVR magnitude and CVR phase to be estimated. This can be achieved by
propagating the errors in the GLM parameter estimates and residuals
through to the ﬁnal CVR estimate. The standard deviation in the CVR
magnitude (σCVRmagX ) can be calculated using Eq. (7), where PEX and σ
2
PEX
are the parameter estimate and the variance in that estimate for protocol
X and σ2Smean is the variance in the mean BOLD signal baseline.
σCVRmagX ¼
PEX
Smean
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
σ2PEX
PE2X
þ σ
2
Smean
S2mean
s
(7)
Since the Sinusoid protocol uses a pair of parameter estimates to
calculate CVR magnitude the variance in those estimates must ﬁrst be
combined using the equation below before application of Eq. (7), where
σ2PEsin and σ
2
PEcos are the variance in the sine and cosine param-
eter estimates.
σ2PEsin=cos ¼
PE2sin
PE2sin þ PE2cos
σ2PEsin þ
PE2cos
PE2sin þ PE2cos
σ2PEcos (8)
However, the absolute error in CVR magnitude does not take into
account the large differences in the scale of CVR magnitude particularly
between grey and white matter. Under these conditions it is preferable to
represent the standard deviation as a fraction of CVR magnitude by
calculating the relative standard deviation (RSD). It should be noted that
the calculation of RSD is the same as for coefﬁcient of variation. How-
ever, the coefﬁcient of variation is usually calculated as the standard
deviation over the mean of repeated measurements. Since here we
calculate the ratio of the error in the parameter over its value we use the
term RSD to reduce ambiguity.
RSDCVRmagX ¼
σCVRmagX
CVRmagX
(9)
Estimating the variance in the CVR phase measurement was only
possible for the Sinusoid protocol due to the use of TFA in the Tor-
onto protocol.
σCVRphasin
¼ 1
1þ PE2sin

PE2cos
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
σ2PEsin
PE2cos
þ σ
2
PEcosPE
2
sin
PE4cos
s
(10)
Details of how to access the code that was used to perform this
analysis can be found in Appendix A.2.4. Stimulus performance
The normocapnic baseline PETCO2 (PETCO2,norm) and the difference
between this baseline and the peak change in PETCO2 (ΔPETCO2), i.e. the
range of PETCO2 change, were measured for each protocol and subject
(Fig. 1a). First, the automated end-tidal picking routine was manually217inspected and corrected where necessary, using software provided with
the RespirAct, to ensure accurate PETCO2 estimation. Linear regression
was then performed using a prototypical model of the stimulus (i.e. a
boxcar temporally aligned with the PETCO2 data or a sine/cosine pair at
16.7 mHz consistent with the Sinusoid protocol's image analysis model
based on Eq. (1)) and a constant term. For the Toronto protocol, the
boxcar representsΔPETCO2 and the constant term represents PETCO2,norm.
However, for the Sinusoid protocol the modulus of the sine/cosine pair
gives the amplitude of the sine wave stimulus and the constant term gives
the baseline of this sine wave. Therefore, in order to report the range of
PETCO2 change consistently, ΔPETCO2 is calculated as twice the ampli-
tude of the sine wave and PETCO2,norm is the value of the sine wave
baseline minus the amplitude of the sine wave stimulus (Fig. 1a).2.5. Comparison between Toronto and Sinusoid protocols
Investigations were made to compare the sensitivity and equivalence
of the two protocols. Firstly, the number of statistically signiﬁcant voxels
that passed the corrected voxel level threshold (GRF-theory-based
maximum height thresholding at p < 0.05) were counted for each subject
and protocol. In order to control for potential differences in subject
motion between protocols the mean motion as calculated during the
motion correction step was extracted (Jenkinson et al., 2002). Mean
motion represents the mean-root-mean square displacement between
adjacent time points and has been shown to be associated with reduced
temporal signal to noise ratio (SNR) in fMRI experiments (Van Dijk et al.,
2012). It is important that the effective temporal SNR is consistent across
protocols in order to isolate the effect of different stimulus paradigm
rather than difference in noise characteristics.
Next the equivalence of the CVR estimates produced by the Toronto
and Sinusoid protocols was explored. A grey matter ROI was deﬁned
based on the grey matter segmentation thresholded at a partial volume
estimate of 0.5. Values of CVR magnitude and phase were extracted from
each subject using this ROI deﬁnition. CVR phase values were corrected
to the mean grey matter phase value to provide a consistent reference
across methods. Furthermore, wrapped phase values were discarded
from the analysis by considering whether the difference between any two
values for a given voxel was greater than ±π, which suggests that the
phase value is wrapped in one protocol but not the other. Systematic
differences between the estimates of CVR magnitude and phase from
each of the protocols were assessed by ﬁtting a simple model: linear slope
(m) and intercept (c). For the CVR magnitude data, a χ2 ﬁt with variance
in the estimates from both protocols was performed by minimising Eq.
(11) to prevent bias (Press, 2007). Variance information was provided by
Eqs. (7) and (8).
XCVRmagsin  m CVRmagtor þ c2
σ2CVRmagsin
þ m2 σ2CVRmagtor
(11)
However, this approach was not possible for the CVR phase data as
the variance could only be calculated for the Sinusoid protocol. Simple
linear regression is not valid in this case because it would implicitly
attribute all of the variance to one of the protocols. Therefore, orthogonal
regression (minimising Eq. (12)) was used whereby the variance in both
methods was assumed to be equal i.e. rather than calculate the vertical
distance from the point to the line, orthogonal regression calculates the
diagonal to the line.
XCVRphasin  m CVRphator þ c2
1þ m2 (12)
For both CVR parameters, magnitude and phase, the estimates are
equivalent if m ≈ 1 and c ≈ 0. Finally, the importance of accounting for
local vascular delays in the Sinusoid protocol was considered. Rather
than use the sine/cosine model, a PETCO2 regressor was created using the
same approach as the Toronto protocol. Comparison was then made with
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were equivalent.
2.6. Effect of reducing Sinusoid protocol scan duration
The effect of reducing the amount of data used to measure the CVR
parameters using the Sinusoid protocol was explored. This was achieved
by truncating the data set at scan durations between 1 min (30 vol) and
6 min (150 vol) in steps of 1 min (30 vol). The full analysis, including pre-
processing and GLM analysis, was performed for each truncated dataset,
and maps of CVR magnitude and phase were generated. High pass tem-
poral ﬁltering at 100 s was disabled for the 1 min scan duration.
The impact of scan time reduction was investigated at the level of
whole brain grey matter. An ROI was generated based on voxels in the
Toronto protocol that met the statistical threshold and was then reﬁned
using a grey matter mask (grey matter segmentation partial volume es-
timate thresholded at 0.5). The mean and standard deviation of the CVR
magnitude and phase values in this ROI were calculated for each scan
duration and subject. In addition, the number of statistically signiﬁcant
voxels from the GLM analysis were calculated for each scan duration and
subject. These results were subjected to a two-way ANOVA test to
investigate the null hypothesis that the group mean values were equal. In
the case that the group mean values were found to be signiﬁcantly
different, pairwise comparison was performed using the Tukey-Kramer
method (honest signiﬁcance difference test) to consider which pairs of
group means were signiﬁcantly different. The Tukey-Kramer method
controls for multiple comparisons by correcting for the family wise error
rate. In this sense it is less conservative than multiple T-tests with Bon-
ferroni correction.
3. Results
Both stimulus protocols yielded reliable and accurate respiratory
challenges. Table 1 details this performance by listing the baseline
PETCO2 and stimulus induced ΔPETCO2. Although within the accuracy of
the end-tidal gas targeting system, on average baseline PETCO2 was
0.9 mmHg higher and ΔPETCO2 was 0.7 mmHg lower for the Toronto
protocol compared with the Sinusoid protocol. Paired two tailed T-tests
showed that these differences were signiﬁcant at p < 0.001 and p < 0.01,
respectively. Although the target of 10 mmHg PETCO2 change was not
attained, all subjects experienced similar PETCO2 changes within a stan-
dard deviation of 1.2 mmHg. The mean PETCO2 change as a function of
time, and the standard deviation, across subjects can also be found in the
supplemental data, alongside the mean grey matter and white matter
BOLD signal change (Fig. S2).
In order to compare the sensitivity of the two protocols the number of
voxels that passed the voxel level statistical threshold were counted.
Table 2 displays these results for the full 7 min data sets, as well as twoTable 1
Respiratory stimulus performance across protocols as deﬁned by baseline normocapnic
PETCO2 (PETCO2,norm) and the change in PETCO2 due to the stimulus (ΔPETCO2).
Subject ID Toronto protocol Sinusoid protocol
PETCO2,norm ΔPETCO2 PETCO2,norm ΔPETCO2
01 38.6 7.0 37.8 7.9
02 37.9 7.1 37.1 8.0
03 43.1 6.2 41.9 6.9
04 43.8 5.0 42.2 5.9
05 40.4 7.4 39.5 7.5
06 31.0 6.0 29.9 6.6
07 41.2 5.3 40.5 6.2
08 40.6 7.9 40.0 8.0
09 38.7 8.0 38.5 8.5
10 38.7 7.7 37.4 9.7
Mean 39.4 6.8 38.5 7.5
SD 3.5 1.1 3.5 1.2
218examples of the truncated Sinusoid protocol data. The mean motion is
also tabulated here to demonstrate the impact of motion on the statistical
maps. Mean motion is fairly consistent between protocols and truncated
data sets, with one exception. Subject 10 shows considerably higher
mean motion for the full Sinusoid protocol compared with the Toronto
protocol or truncated data sets. Further investigation revealed large
translations in the last two stimulus cycles. Since this would lead to a
varying error contribution in the GLM analysis across truncated data sets,
this subject was excluded from further analysis. For the remaining sub-
jects, a paired two-tailed T-test showed that the number of statistically
signiﬁcant voxels was insigniﬁcantly different between the Toronto and
Sinusoid protocols (p ¼ 0.36).
Examples of the main outputs of the analysis are displayed for both
protocols in Fig. 2, consisting of unthreholded Z-statistic maps, CVR
magnitude, CVR magnitude RSD, CVR phase and CVR phase standard
deviation (SD). Both protocols can be seen to produce qualitatively
similar results. A reduced Z-statistic value is observed in the Sinusoid
protocol compared with the Toronto protocol (Fig. 2a/e). However,
similar grey matter to white matter contrast is observed across CVR
magnitude (Fig. 2b/f) and phase (Fig. 2d/h) maps. Similarly estimates of
the error in these parameters demonstrate increased variance in white
matter compared with grey matter. To investigate the quantitative
equivalence of the protocols estimates of CVR magnitude and CVR phase
were plotted on a voxel-by-voxel basis for each subject. Fig. 3a and
d shows an example subject for CVR magnitude and phase, respectively.
Per subject estimates of the slope and intercept for CVRmagnitude reveal
that the group mean slope (1.05 ± 0.11, mean ± s.d.) is not signiﬁcantly
different from unity (p ¼ 0.24, Fig. 3b), but the group mean intercept
(0.03 ± 0.03) is signiﬁcantly different from zero (p < 0.05, Fig. 3c). For
CVR phase the group mean slope (0.64 ± 0.17) and intercept
(0.05± 0.05) are signiﬁcantly different from unity and zero, respectively,
at p< 0.05. Further comparison of the Toronto protocol with the Sinusoid
protocol analysed using a PETCO2 regressor in the same manner as the
Toronto protocol was also performed (Fig. S3). Under these conditions
the estimates of CVR magnitude were not found to be equivalent with
group mean slope (0.51 ± 0.16) and intercept (0.00 ± 0.01) being
signiﬁcantly different (p < 0.05) from unity and zero, respectively.
An example of the effect of reducing scan duration is displayed in
Fig. 4. Two examples of the truncated Sinusoid protocol (5 min and
3 min) are presented alongside the full 7 min acquisition. Values of the Z-
statistic can be seen to reduce with the amount of data included in the
analysis (Fig. 4a–c). CVR magnitude maps look qualitatively very similar
across scan durations (Fig. 4d–f), whilst CVR phase maps show some
small differences when only 3 min of data are used (Fig. 4g–i). This is
further explored across all subjects in Fig. 5. The group mean of the mean
CVRmagnitude across the ROI (Fig. 5a) was seen to increase slightly with
reduced scan time. A two-way ANOVA test showed that not all group
means were equal (p < 0.001), but a paired multiple comparisons anal-
ysis showed that only the 1 min duration was signiﬁcantly different
(p < 0.001) to the full data set. A similar increase was observed for the
group mean standard deviation of the CVR magnitude (Fig. 5b). Again
group means were not all equal (p < 0.001) and only the 1 min duration
was signiﬁcantly different (p < 0.001) to the full data set. The group
mean of the mean CVR phase displayed little variation (Fig. 5c) and was
not signiﬁcant (p ¼ 0.99). The group mean of the standard deviation of
the CVR phase showed the largest increase with time reduction (Fig. 5d).
The group means were signiﬁcantly different (p < 0.001) and the 1 min
(p < 0.001) and 2 min (p < 0.01) scan durations were signiﬁcantly
different to the full data set. The group mean number of statistically
signiﬁcant voxels (Fig. 5e) reduced with scan time and were signiﬁcantly
different (p < 0.001). Pairwise comparison revealed signiﬁcant differ-
ences between the 1, 2 and 3 min durations (p < 0.001) and the full data
set. Finally, for comparison Fig. 5f scales the group means of the standard
deviation of the CVR magnitude and phase to the full data set, demon-
strating a larger effect of scan time reduction on CVR phase than
CVR magnitude.
Table 2
Number of voxels above the voxel level statistical threshold for the 7 min datasets of each protocol and the Sinusoid protocol truncated at 5 min and 3 min. The mean motion, deﬁned as
average root mean square displacement between adjacent time points, for each data set is presented alongside voxel count to highlight the effect of subject motion.
Subject ID Toronto protocol Sinusoid protocol
7 min 7 min 5 min 3 min
#voxels Motion #voxels Motion #voxels Motion #voxels Motion
01 18995 0.11 17089 0.10 14735 0.10 10345 0.11
02 15650 0.13 17054 0.10 15969 0.10 15380 0.11
03 17820 0.14 15104 0.15 14221 0.14 13695 0.13
04 9590 0.20 10174 0.20 8736 0.20 5013 0.19
05 16828 0.09 17185 0.09 15764 0.09 13941 0.09
06 5090 0.27 7106 0.29 6895 0.29 4785 0.22
07 15507 0.20 14643 0.24 12490 0.22 12081 0.21
08 19356 0.23 12400 0.30 10986 0.32 8070 0.34
09 19333 0.08 19507 0.12 17852 0.12 15109 0.10
10 19630 0.19 6767 0.40 15776 0.21 12890 0.22
Mean 15780 0.16 13703 0.20 13343 0.18 11131 0.17
SD 4814 0.06 4437 0.11 3509 0.08 3945 0.08
Fig. 2. Example CVR maps from a single subject (Subject 01). A subset of ﬁve contiguous slices are displayed superior to the lateral ventricles. Maps (a)–(d) were produced using the
Toronto protocol and (e)–(i) using the Sinusoid protocol. Maps were generated to display (a/e) statistical correlation with the CO2 stimulus (Z-statistic), (b/f) CVR magnitude (normalised
by the change in PETCO2), (c/g) relative standard deviation (RSD) of the CVR magnitude estimate, (d/h) CVR phase and (i) standard deviation of the CVR phase estimate. Note: It is not
possible to generate maps of the error in CVR phase for the Toronto protocol.
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CVR mapping using MRI is a promising clinical tool for stress testing
cerebral blood vessels. However, there are several aspects of current CVR
mapping techniques that limit their clinical application. In this study we
concentrated on minimising the scan duration in order to improve the
compatibility of this technique with clinical workﬂows. By utilising a
sinusoidally modulated hypercapnia challenge we were able to retro-
spectively examine the effect of reducing the scan duration. In turn we
were able to demonstrate that good quality CVR maps can be acquired in
around 3 min, rather than the more typical 7 min. Furthermore, we
demonstrated that CVR magnitude maps generated using this sinusoidal
stimulus are equivalent to the more conventional block paradigm.2194.1. Stimulus performance
Gas stimulus protocols were tailored to each subject's individual
baseline PETCO2. This baseline was maintained within 1 mmHg between
the protocols, but was statistically signiﬁcantly different none the less.
The temporal characteristics of the stimuli were well reproduced for both
protocols (Fig. S2). Since the vascular response to carbon dioxide is
sigmoidal in form in healthy subjects (Bhogal et al., 2014) it is possible
that the two protocols were performed on different parts of the sigmoid
curve. However, in practice maintaining baseline PETCO2 to a higher
accuracy than 1 mmHg is challenging. Both stimulus protocols elicited
PETCO2 changes of the order of 7 mmHg, which should place the vascular
response within the linear regime of the sigmoidal vascular response
(Bhogal et al., 2014). A statistically signiﬁcant difference inΔPETCO2 was
Fig. 3. Estimates of (a) CVR magnitude and (d) CVR phase were compared on a voxel-by-voxel basis for each subject (single example subject shown). The slope and intercept of this
relationship were estimated (plotted as a dashed line and compared to the solid line of unity). For CVR magnitude, the mean slope (b) was not signiﬁcantly different to unity, suggesting the
protocols give equivalent estimates. However, the intercept (c) was found to be signiﬁcantly different to zero (p < 0.05), resulting in a mean intercept of 0.03%/mmHg. For CVR phase, the
mean slope (e) was signiﬁcantly different to unity (p < 0.05), indicating that these measures are not equivalent, whilst the intercept (f) was not signiﬁcantly different from zero.
Fig. 4. Example single slice of CVR maps from the Sinusoid protocol as scan duration is
reduced (Subject 01) for (a)–(c) statistical correlation, (d)–(f) CVR magnitude and (g)–(i)
CVR phase.
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0.7 mmHg. Since CVR magnitude values are normalised by ΔPETCO2 this220should not produce a bias between the protocols. Unfortunately, subject
tolerance of both stimulus protocols was not recorded. However, none of
the subjects reported discomfort from either stimulus protocol.4.2. Comparison between Toronto and Sinusoid protocols
Before discussing the results of the protocol comparison it is useful to
consider the advantages and disadvantages of the two stimulus protocols.
As a more conventional block paradigm, the Toronto protocol is an easier
stimulus to implement. However, synchronisation of the measured
PETCO2 experienced by the subject with the BOLD data is critical to the
accurate estimation of magnitude of the CVR change. Whilst this is
practical when synchronising with the whole brain average BOLD signal,
the presence of local variations in vascular response delay open up the
possibility of the underestimation of CVR magnitude, or the measure-
ment of spurious negative signal changes (Dufﬁn et al., 2015). This can
be mitigated by the use of long blocks of hypercapnia, but therefore limits
how short the total acquisition can be. In contrast sinusoidal stimuli have
seen only limited application (Driver et al., 2015). To be clinically
practical, computer controlled gas delivery is desirable, although a
manual implementation has also been demonstrated (Liu et al., 2016). In
the previous implementation a Fourier analysis approach was used based
on in-house analysis software (Blockley et al., 2010). However, in this
study we reframe the analysis in order to use free and widely available
fMRI analysis tools (Jenkinson et al., 2012). One of the inherent ad-
vantages of the Sinusoid protocol is its insensitivity to local vascular
response delays. This is due to the fact that any sinusoid with arbitrary
amplitude and phase can be represented by the sum of a sine and a cosine
with different amplitudes (Eq. (1)). In this context only the frequency of
Fig. 5. Analysis of the effect of reducing the scan duration of the Sinusoid protocol for (a/b) CVR magnitude, (c/d) CVR phase and (e) the number of voxels above the voxel level statistical
threshold. Analysis was performed for a grey matter region of interest (ROI) where the mean and standard deviation of the estimates within the ROI were calculated. The standard
deviation of the CVR magnitude and phase are compared directly (f) by normalising to the 7 min scan duration.
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N.P. Blockley et al. NeuroImage 159 (2017) 214–223the stimulus is important, rather than the timing. This enables the short
time period stimuli used in this work, which would otherwise result in
underestimates, or artefactual negative values, of CVR magnitude.
Negative values could be caused by very long combined transit and
vascular delays, for instance in the case of collateral ﬂow in disease,
leading to positive increases in ﬂow that are in anti-phase with the
stimulus. Finally, simple sine and cosine functions were used as re-
gressors in the GLM analysis, rather than the measured PETCO2 time-
course. Despite this, the number of statistically signiﬁcant voxels
(Table 2) was not signiﬁcantly different to the Toronto protocol across
the group. This approach simpliﬁes the analysis as the PETCO2 data does
not need to be transferred to the analysis computer and synchronised
with the BOLD data. However, it should be noted that the PETCO2 re-
gressor for the Toronto protocol was aligned with the global brain signal
and therefore, unlike the Sinusoid protocol, voxel level correction for
delays was not performed. It is possible this could have resulted in fewer
signiﬁcant voxels, however, large deviations from the global brain signal
delay within grey matter are unlikely in this healthy cohort, although the
variations between grey and white matter still have the potential to be
large. Delays of this magnitude are accounted for in the analysis of the
Sinusoid protocol. However, the maximum time delay that can be
tolerated by this protocol is determined by the time period of the stim-
ulus. In this case relative delays over 60 s will result in phase wrapping
meaning that such delays are indistinguishable from no delay. Larger
delays can be measured by using a stimulus with a longer time period. In
addition, the symmetric nature of the sinusoidal stimulus means
anti-phase responses to the stimulus cannot be distinguished from
negative responses using the current analysis approach. This is one of the
advantages of the asymmetric Toronto protocol. However, such infor-
mation can in theory be extracted from the Sinusoid protocol using a
model based analysis incorporating an initial delay at baseline to reﬂect
the increased vascular response time.
Maps of CVR magnitude were found to have qualitatively similar
features (Fig. 2b/f). Furthermore, quantitative analysis comparing CVR
magnitude on a voxel-by-voxel basis (Fig. 3a) showed that the slope
between the protocols was not signiﬁcantly different to unity (Fig. 3b),
but that the intercept was signiﬁcantly different from zero (Fig. 3c). This
can be interpreted as a constant offset, or bias, of 0.03%/mmHg. How-
ever, this is unlikely to have a practical impact on maps of CVR magni-
tude. By utilising estimates of the variance in the parameter estimates
and the residuals from the GLM analysis it was possible to evaluate the
standard deviation of the CVR magnitude measurement. By presenting
this as the relative standard deviation (RSD), with respect to the mean,
the large degree of heterogeneity in CVR magnitude is controlled,
revealing more noisy estimates in white matter (Fig. 2c/g). However, the
standard deviation in CVR magnitude, as estimated using Eq. (7), should
be viewed with caution as it relies on the variance in Smean from the
residuals. The residuals include contributions from motion and physio-
logical noise that aren't included in the GLM model. Therefore, large
amounts of motion will result in larger values of RSD, in effect being
categorised as noise.
The importance of accounting for local delays was also demonstrated
by analysing the Sinusoid protocol in the same manner as the Toronto
protocol i.e. using a time aligned PETCO2 regressor. Using the same
analysis as Fig. 3, but only for CVR magnitude, revealed that the slope
and gradient relationship with the Toronto protocol (Fig. S3) were
signiﬁcantly different to unity and zero, respectively. This suggests that
the CVR magnitude estimates are not equivalent. Since the PETCO2 re-
gressor was only aligned to the global signal, local vascular response
delays were not accounted for. Such delays are a signiﬁcant fraction of
the stimulus duration for shorter stimuli, resulting in an underestimate of
the CVR magnitude. However, this is not an issue speciﬁc to the Sinusoid
protocol, but is likely to be encountered with any short time period
stimulus. Since short stimuli are required to reduce scan duration, it is
important to ensure this is adequately accounted for.
Maps of CVR phase also showed clear similarities between methods222(Fig. 2d/h). Quantitative analysis was performed on a voxel-by-voxel
basis (Fig. 3d). However, the slope was found to be signiﬁcantly
different to unity (Fig. 3e), suggesting that the estimates of the two
protocols are not equivalent. Values of the intercept were not signiﬁ-
cantly different to zero. This disparity may be due to the large difference
in stimulus duration between the Toronto (45–120 s above baseline
PETCO2) and the Sinusoid protocol (30 s above baseline PETCO2 in each
60 s cycle). Due to the more sustained nature of the Toronto protocol the
vascular response is likely to reach a new steady state, enabling vascular
steal effects to manifest in disease. In contrast the shorter stimulus
duration of the Sinusoid protocol may not allow such steal effects to be
revealed. Therefore, further optimisation of the time period of the
Sinusoid stimulus is required in a patient cohort. However, this frequency
dependence of the CVR response may also provide an additional window
on the underlying vascular physiology.
Maps of the standard deviation of the CVR phase measurement were
estimated for the Sinusoid protocol by propagating the errors in the
parameter estimates (Fig. 2i). RSD was not used because of the relative
nature of phase i.e. the reference phase is arbitrary. It is not possible to
estimate the standard deviation of the Toronto CVR phase due to the use
of TFA, although an analysis of the effects of noise was included in the
original paper (Dufﬁn et al., 2015).
4.3. Effect of reducing Sinusoid protocol scan duration
Rather than acquire multiple scans with different durations, the same
7 min protocol was truncated to investigate the effect of reducing scan
duration. From a qualitative perspective, whilst the values of the Z-sta-
tistic are reduced with decreasing scan duration, there appears to be
relatively little effect on maps of CVRmagnitude at scan durations of 3 or
5 min, and only small differences in the 3 min CVR phase map (Fig. 4).
Quantitative analysis conﬁrmed that the number of above threshold
voxels in the Z-statistic maps was signiﬁcantly different in the 1, 2 and
3 min scan durations when compared with the full data set. Furthermore,
the results in Fig. 5e are consistent with the expected reduction in
sensitivity demonstrated for fMRI analysis (Murphy et al., 2007). CVR
magnitude was only minimally affected, consistent with the qualitative
assessment above, with only the 1 min scan duration found to be
signiﬁcantly different to the full data set for both the mean and standard
deviation across the ROI. Estimates of CVR phase appear to be more
strongly affected by scan time reduction. Whilst the mean over the ROI
was not signiﬁcantly different as a function of scan duration, the standard
deviation was signiﬁcantly different for the 1 and 2 min durations. This
increased sensitivity of CVR phase to scan time reduction, relative to CVR
magnitude, was highlighted by normalising Fig. 5b and d to their 7 min
values. The standard deviation of CVR phase over the ROI clearly in-
creases much more rapidly for CVR phase than CVR magnitude, neces-
sitating longer scan duration where CVR phase is a priority. In summary,
the results would suggest that scan time could be reduced to be in the
range of 3–5 min with minimal effect on the resulting maps of CVR.
4.4. Limitations and future work
In the current implementation of this technique, long patient prepa-
ration times remain the largest barrier to clinical adoption. Whilst it was
not the aim of this study to tackle this problem, it does deserve further
consideration. To maintain a constant PETCO2 baseline with minimal drift
using the prospective end-tidal gas targeting system used in this study,
the system must be calibrated to each individual. In our hands this pro-
cess takes about 30 min, including application of the mask, although it
may be shorter for more experienced users. However, there is a great deal
of scope for time reduction by automating this calibration step, which
will likely be implemented in future hardware developments. In the short
term, using the current hardware, it should still be possible to realise
shorter patient preparation times, albeit at the expense of a small amount
of PETCO2 baseline drift. As noted above, the gas targeting system
N.P. Blockley et al. NeuroImage 159 (2017) 214–223provides an initial setup based on the height, weight and age of the
subject. The calibration process enables this setup to be reﬁned. How-
ever, the initial estimate results in only small amounts of drift in many
cases. Small amounts of drift are removed by the high-pass temporal ﬁlter
and will not affect estimates of CVR so long as the vasculature remains in
the linear regime of the sigmoidal vascular response. Further work is
required to investigate this approach.
It also wasn't possible to examine the hypothesis that the Sinusoid
protocol should be better able to account for local variations in vascular
response delay using the data from this healthy cohort. Data acquired in
patients where long transit or vascular response delays will be required to
conﬁrm this.
5. Conclusions
In this study we have demonstrated that a sinusoidal hypercapnia
stimulus provides equivalent information about CVR to a conventional
block paradigm. Furthermore, we have shown that the scan duration of
the Sinusoid protocol can be drastically reduced with only a small effect
on the resulting CVR maps. This development should enable scan dura-
tions between 3 and 5 min and has the potential to enable more wide-
spread clinical adoption.
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Appendix A. Supplementary data
The raw data that underpins this work can be accessed via the Oxford
Research Archive repository, doi: https://doi.org/10.5287/bodleian:
Xk48adQAO. Furthermore, the code to perform the analyses on these
data can be accessed via the Zenodo repository, doi: https://doi.org/10.
5281/zenodo.495612. Supplementary data related to this article can be
found at http://dx.doi.org/10.1016/j.neuroimage.2017.07.048.
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